Chandra Bhagat PharmaBOM:542934 -4.98%70 Interest Coverage is 1.42 as of Mar. 2026, which is 5% below its 10-year median of 1.49. GuruFocus rates BOM:542934 with a GF Score™ of 70/100 and a GF Value™ of ₹70.20 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 89 Medical Distribution companies, Chandra Bhagat Pharma ranks worse than 93.26% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Chandra Bhagat Pharma's
Operating Income
for the
six
months ended in Mar. 2026 was ₹17 Mil. Chandra Bhagat Pharma's Interest Expense for the
six
months ended in Mar. 2026 was ₹-12 Mil.
Chandra Bhagat Pharma's interest coverage for the quarter that ended in Mar. 2026 was 1.42.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Chandra Bhagat Pharma's Interest Coverage or its related term are showing as below:
BOM:542934'
s Interest Coverage Range Over the Past 10 Years
Min: 1.1 Med: 1.49 Max: 1.82
Current: 1.38
BOM:542934's Interest Coverage is ranked worse than 93.26% of 89
companies
in the Medical Distribution industry
Industry Median: 6.23
vs BOM:542934: 1.38
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Chandra Bhagat Pharma Interest Coverage Related Terms
Chandra Bhagat Pharma Interest Coverage Historical Data
* Premium members only.
The historical data trend for Chandra Bhagat Pharma's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
BOM:542934 vs MCK, CAH, COR: Interest Coverage Comparison
For the Medical Distribution subindustry, Chandra Bhagat Pharma's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chandra Bhagat Pharma Interest Coverage vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Chandra Bhagat Pharma's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Chandra Bhagat Pharma's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chandra Bhagat Pharma (BOM:542934) has a Interest Coverage of 1.42 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Chandra Bhagat Pharma and its competitors. This is near median its historical median of 1.49. Over the past decade, Chandra Bhagat Pharma's Interest Coverage has ranged from 1.10 to 1.82. According to the industry distribution chart, Chandra Bhagat Pharma ranks #83 out of 89 companies in the Medical Distribution industry, placing it in the top 93.3%.
Is Chandra Bhagat Pharma's Interest Coverage too high?
Chandra Bhagat Pharma's current Interest Coverage of 1.42 is near median its 10-year median of 1.49. Over the past 10 years, this metric has ranged from a low of 1.10 to a high of 1.82. The Medical Distribution industry median Interest Coverage is 6.23. Chandra Bhagat Pharma's value of 1.42 is 77.2% below this industry median. Based on the distribution chart, Chandra Bhagat Pharma ranks #83 out of 89 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Chandra Bhagat Pharma has a GF Score™ of 70/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Chandra Bhagat Pharma's Interest Coverage compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Chandra Bhagat Pharma ranks #83 out of 89 companies for Interest Coverage. This places Chandra Bhagat Pharma in the lower half of its industry. The industry median Interest Coverage is 6.23. Chandra Bhagat Pharma's value of 1.42 is 77.2% below this benchmark. Historically, Chandra Bhagat Pharma's own Interest Coverage has ranged from 1.10 to 1.82 over the past decade. While the company's 10-year median is 1.49 vs. the industry median of 6.23, Chandra Bhagat Pharma has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Distribution company?
The median Interest Coverage among Medical Distribution companies is 6.23, based on 89 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chandra Bhagat Pharma's current Interest Coverage of 1.42 is 77.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Chandra Bhagat Pharma and its competitors. For the Medical Distribution industry, the median Interest Coverage is 6.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chandra Bhagat Pharma's current Interest Coverage is 1.42, which is near median its own 10-year median of 1.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chandra Bhagat Pharma stock overvalued right now?
Based on GuruFocus' analysis, Chandra Bhagat Pharma (BOM:542934) is currently considered Possible Value Trap. The stock's GF Value™ is ₹70.20, compared to a current price of ₹38.55 — trading 45.1% below its estimated fair value. The current Interest Coverage is 1.42, which is near median its 10-year median of 1.49 and 77.2% below the Medical Distribution industry median of 6.23. Chandra Bhagat Pharma's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Chandra Bhagat Pharma (BOM:542934), the current Interest Coverage is 1.42 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chandra Bhagat Pharma (BOM:542934) Overvalued in 2026?
Based on GuruFocus' analysis, Chandra Bhagat Pharma stock appears to be undervalued.
The current stock price of ₹38.55 is trading 45.1% below its estimated GF Value™ of ₹70.20.
GuruFocus considers Chandra Bhagat Pharma to be Possible Value Trap.
Key valuation signals for BOM:542934:
Interest Coverage: 1.42 (near median its 10-year median of 1.49)
GF Value™: ₹70.20 vs. price of ₹38.55 (45.1% below fair value)
Industry Position: 77.2% below the Medical Distribution median (#83 of 89)
No single metric tells the full story. See the BOM:542934 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chandra Bhagat Pharma Ltd is a pharmaceutical company marketing pharmaceutical, critical care, and health care products across the globe. The company deals in many categories of pharmaceutical products like anticancer, cardiovascular, anti-infective, etc. It offers various forms of pharmaceutical products, like oral solids. tablets, capsules, liquid orals, syrup suspension, injections, liquid, powder, etc. Additionally, the company is also engaged in promoting and marketing of Active Pharmaceutical Ingredients (API's) in India.
70GF Score
Get the complete analysis for BOM:542934
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:542934 has been successfully added to your 
